Prophylaxis of cytomegalovirus disease with intravenous ganciclovir in renal transplantation

Transplant Proc. 1999 Sep;31(6):2337-8. doi: 10.1016/s0041-1345(99)00367-x.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Antiviral Agents / therapeutic use*
  • Cytomegalovirus Infections / prevention & control*
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Ganciclovir / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation* / physiology
  • Male
  • Middle Aged
  • Postoperative Complications
  • Time Factors

Substances

  • Antiviral Agents
  • Immunosuppressive Agents
  • Ganciclovir